Login or sign up
For business

Vanda pharmaceuticals inc.

4.1· 10 reviews
Average ratingGreat
4.1/ 5

Based on 10 reviews

540%
430%
330%
20%
10%
Ask AI

Ask Trustburn about Vanda pharmaceuticals inc.

Based on 10 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Vanda pharmaceuticals inc.

Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.

Vanda Pharmaceuticals Inc. is a global biopharmaceutical company that is dedicated to developing and commercializing innovative therapies to address high unmet medical needs and improve the lives of patients. The company has a strong focus on research and development, with a pipeline of promising drug candidates in various stages of clinical trials.

Founded in 2002, Vanda Pharmaceuticals has grown into a leading player in the biopharmaceutical industry, with operations spanning across North America, Europe, and Asia. The company's mission is to discover new treatments for diseases that have limited or no treatment options available.

Vanda's core therapeutic areas include central nervous system disorders (CNS), sleep disorders, oncology, and immunology. The company's flagship product is Hetlioz® (tasimelteon), which was approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24).

In addition to Hetlioz®, Vanda has several other promising drug candidates in its pipeline that are being developed for various indications such as schizophrenia, jet lag disorder, atopic dermatitis, among others.

One of Vanda's key strengths lies in its ability to leverage cutting-edge technologies such as genomics and proteomics to identify novel targets for drug discovery. The company also collaborates with leading academic institutions and research organizations worldwide to advance its R&D efforts.

Vanda Pharmaceuticals' commitment towards innovation extends beyond drug development; it also encompasses novel approaches towards drug delivery systems. For instance, the company has developed Fanapt® I.V., an intravenous formulation of iloperidone used for treating acute agitation associated with schizophrenia or bipolar mania.

The success of Vanda Pharmaceuticals can be attributed not only to its strong R&D capabilities but also its experienced management team led by CEO Mihael Hristoskov Paunov who brings over 20 years of experience in the biopharmaceutical industry. The company's board of directors comprises seasoned professionals with extensive experience in drug development, finance, and business strategy.

In conclusion, Vanda Pharmaceuticals Inc. is a global biopharmaceutical company that is dedicated to developing innovative therapies to address high unmet medical needs. With a strong focus on R&D and cutting-edge technologies, the company has established itself as a leading player in the industry. Its commitment towards innovation and collaboration with leading academic institutions and research organizations worldwide positions it well for continued success in the future.

Address
2200 pennsylvania avenue northwest
Categories
Pharmaceuticals